✦ LIBER ✦

No Influence of Mild-To-Moderate Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of Ximelagatran, an Oral Direct Thrombin Inhibitor

✍ Scribed by Dr Karin Wåhlander, Maria Eriksson-Lepkowska, Lars Frison…

Book ID: 120803876
Publisher: Springer International Publishing AG
Year: 2003
Tongue: English
Weight: 131 KB
Volume: 42
Category: Article
ISSN: 0312-5963
DOI: 10.2165/00003088-200342080-00004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Influence of Age on the Pharmacokinetics

Influence of Age on the Pharmacokinetics and Pharmacodynamics of Ximelagatran, an Oral Direct Thrombin Inhibitor

✍ Linda C. Johansson, Lars Frison, Ulrika Logren, Gunnar Fager, David Gustafsson, 📂 Article 📅 2003 🏛 Springer International Publishing AG 🌐 English ⚖ 157 KB

No Influence of Obesity on the Pharmacok

No Influence of Obesity on the Pharmacokinetics and Pharmacodynamics of Melagatran, the Active Form of the Oral Direct Thrombin Inhibitor Ximelagatran

✍ Dr Troy C. Sarich, Renli Teng, Gary R. Peters, Maria Wollbratt, Robert Homolka, 📂 Article 📅 2003 🏛 Springer International Publishing AG 🌐 English ⚖ 124 KB

No Influence of Ethnic Origin on the Pha

No Influence of Ethnic Origin on the Pharmacokinetics and Pharmacodynamics of Melagatran Following Oral Administration of Ximelagatran, a Novel Oral Direct Thrombin Inhibitor, to Healthy Male Volunteers

✍ Linda C. Johansson, Magnus Andersson, Gunnar Fager, David Gustafsson, Dr Ulf G. 📂 Article 📅 2003 🏛 Springer International Publishing AG 🌐 English ⚖ 156 KB

No influence of moderate hepatic impairm

No influence of moderate hepatic impairment on the pharmacokinetics of lumiracoxib, an oral COX-2 selective inhibitor

✍ J Kalbag; C.-M Yeh; S Milosavljev; K Lasseter; S Oberstein; C Rordorf 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Pharmacokinetics and pharmacodynamics of

Pharmacokinetics and pharmacodynamics of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, are not influenced by acetylsalicylic acid

✍ Gunnar Fager; Marie Cullberg; Maria Eriksson-Lepkowska; Lars Frison; Ulf G. Erik 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 311 KB

Effect of hepatic impairment on the phar

Effect of hepatic impairment on the pharmacokinetics and pharmacodynamics of a single dose of rivaroxaban, an oral, direct Factor Xa inhibitor

✍ Kubitza, Dagmar; Roth, Angelika; Becka, Michael; Alatrach, Abir; Halabi, Atef; H 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 435 KB